The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice
- PMID: 34653361
- PMCID: PMC8665053
- DOI: 10.1016/j.cub.2021.09.049
The dihydropyrimidine dehydrogenase gene contributes to heritable differences in sleep in mice
Abstract
Many aspects of sleep are heritable, but only a few sleep-regulating genes have been reported. Here, we leverage mouse models to identify and confirm a previously unreported gene affecting sleep duration-dihydropyrimidine dehydrogenase (Dpyd). Using activity patterns to quantify sleep in 325 Diversity Outbred (DO) mice-a population with high genetic and phenotypic heterogeneity-a linkage peak for total sleep in the active lights off period was identified on chromosome 3 (LOD score = 7.14). Mice with the PWK/PhJ ancestral haplotype at this location demonstrated markedly reduced sleep. Among the genes within the linkage region, available RNA sequencing data in an independent sample of DO mice supported a highly significant expression quantitative trait locus for Dpyd, wherein reduced expression was associated with the PWK/PhJ allele. Validation studies were performed using activity monitoring and EEG/EMG recording in Collaborative Cross mouse strains with and without the PWK/PhJ haplotype at this location, as well as EEG and EMG recording of sleep and wake in Dpyd knockout mice and wild-type littermate controls. Mice lacking Dpyd had 78.4 min less sleep during the lights-off period than wild-type mice (p = 0.007; Cohen's d = -0.94). There was no difference in other measured behaviors in knockout mice, including assays evaluating cognitive-, social-, and affective-disorder-related behaviors. Dpyd encodes the rate-limiting enzyme in the metabolic pathway that catabolizes uracil and thymidine to β-alanine, an inhibitory neurotransmitter. Thus, data support β-alanine as a neurotransmitter that promotes sleep in mice.
Keywords: Collaborative Cross; Diversity Outbred; Dpyd; dihydropyrimidine dehydrogenase; genetics; knockout; mice; sleep.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.I.P. is The John L. Miclot Professor of Medicine at the University of Pennsylvania; funds for this endowment were provided by the Philips Respironics Foundation. G.A.C., E.J.C., and K.L.S. disclose that The Jackson Laboratory produces and sells a wide variety of mice for research, including Collaborative Cross and Diversity Outbred mice. The other authors declare no competing interests.
Figures




Similar articles
-
Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene.Biochim Biophys Acta. 2016 Apr;1862(4):754-762. doi: 10.1016/j.bbadis.2016.01.009. Epub 2016 Jan 12. Biochim Biophys Acta. 2016. PMID: 26804652
-
Haplotype structure defines effects of common DPYD variants c.85T > C (rs1801265) and c.496A > G (rs2297595) on dihydropyrimidine dehydrogenase activity: Implication for 5-fluorouracil toxicity.Br J Clin Pharmacol. 2021 Aug;87(8):3234-3243. doi: 10.1111/bcp.14742. Epub 2021 Mar 30. Br J Clin Pharmacol. 2021. PMID: 33491253 Free PMC article.
-
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score.Pharmacogenomics. 2015;16(11):1277-86. doi: 10.2217/pgs.15.70. Epub 2015 Aug 12. Pharmacogenomics. 2015. PMID: 26265346 Review.
-
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.Cancer Chemother Pharmacol. 2016 Oct;78(4):875-80. doi: 10.1007/s00280-016-3137-0. Epub 2016 Aug 20. Cancer Chemother Pharmacol. 2016. PMID: 27544765
-
Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines.Int J Clin Oncol. 2003 Jun;8(3):132-8. doi: 10.1007/s10147-003-0330-z. Int J Clin Oncol. 2003. PMID: 12851836 Review.
Cited by
-
Investigating Neuron Degeneration in Huntington's Disease Using RNA-Seq Based Transcriptome Study.Genes (Basel). 2023 Sep 14;14(9):1801. doi: 10.3390/genes14091801. Genes (Basel). 2023. PMID: 37761940 Free PMC article.
-
Into the Wild: A novel wild-derived inbred strain resource expands the genomic and phenotypic diversity of laboratory mouse models.PLoS Genet. 2024 Apr 10;20(4):e1011228. doi: 10.1371/journal.pgen.1011228. eCollection 2024 Apr. PLoS Genet. 2024. PMID: 38598567 Free PMC article.
-
Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: A perspective from studies in model organisms.Sleep Med Rev. 2022 Apr;62:101595. doi: 10.1016/j.smrv.2022.101595. Epub 2022 Jan 25. Sleep Med Rev. 2022. PMID: 35158305 Free PMC article. Review.
-
Rare Genetic Variants Provide Protection for Obstructive Sleep Apnea.Am J Respir Crit Care Med. 2022 Nov 15;206(10):1199-1200. doi: 10.1164/rccm.202207-1414ED. Am J Respir Crit Care Med. 2022. PMID: 35904813 Free PMC article. No abstract available.
References
-
- Aguiar GF, da Silva HP, Marques N. Patterns of daily allocation of sleep periods: a case study in an Amazonian riverine community. Chronobiologia. 1991; 18 (1): 9–19. - PubMed
-
- Hur Y-M, Bouchard TJ Jr., Lykken DT. Genetic and environmental influence on morningness-eveningness. Personality and Individual Differences. 1998; 25 (5): 917–925.
-
- Vink JM, Groot AS, Kerkhof GA, Boomsma DI. Genetic analysis of morningness and eveningness. Chronobiol Int. 2001; 18 (5): 809–822. - PubMed
-
- Klei L, Reitz P, Miller M, et al. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int. 2005; 22 (6): 1041–1054. - PubMed
-
- Heath AC, Kendler KS, Eaves LJ, Martin NG. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep. 1990; 13 (4): 318–335. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases